Anpac Bio is launching a new facility in Pennsylvania.
U.S. Technical Team

U.S. Technical Team

Dr. Herbert Yu

Co-Founder/Chief Science Officer

Dr. Herbert Yu is an M.D, with a Ph.D. in Clinical Biochemistry from University of Toronto. He is a highly acclaimed research director and professor in epidemiology and cancer research at Yale University and University Hawaii.

DR. LEE P. SHULMAN

TECHNICAL BOARD CONSULTANT

Dr. Shulman is the Chief of the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University

DR. JOHN J. REDDINGTON

TECHNICAL BOARD CONSULTANT

Dr. Reddington was the former Chief Operating Officer for Cambridge Biomedical Inc., a privately held laboratory CRO

ALFRED LUI, M. D., FCAP

CLIA LABORATORY DIRECTOR

Dr. Lui is an American Board of Pathology diplomat certified in anatomic and clinical pathology, and he has extensive experience as the Director of CLIA certified and CAP accredited laboratories.

SHARON VORSE-YU, M.S.

VP of Technical Operations

Sherry's focus is on bio-medical CLIA lab set-up and certification. She is responsible for working, on a technical level, with Anpac Bio’s medical groups and hospital partners, and with our leading medical and bio-science university partners.